Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
24.99
+1.32 (5.58%)
At close: Aug 10, 2026, 4:00 PM EDT
25.42
+0.43 (1.72%)
Pre-market: Aug 11, 2026, 4:00 AM EDT

Omada Health Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $26.67. The average 1-year stock price forecast is 6.72% higher than the current stock price, while the lowest is $15 (-39.98%) and the highest is $35 (+40.06%).

Price Target: $26.67 (+6.72%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$15$26.67$26.5$35
Change-39.98%+6.72%+6.04%+40.06%

Analyst Ratings

The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy555555
Buy445555
Hold222222
Sell000000
Strong Sell000000
Total111112121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$28
BuyMaintains$28+12.04%Aug 7, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$25
BuyMaintains$25+0.04%Aug 7, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$30
BuyMaintains$30+20.05%Aug 7, 2026
BMO Capital
BMO Capital
Buy
Reiterates
$20$24
BuyReiterates$20$24-3.96%Aug 7, 2026
Needham
Needham
Buy
Reiterates
$28
BuyReiterates$28+12.04%Aug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
338.96M
from 260.21M
Increased by 30.26%
Revenue Next Year
401.52M
from 338.96M
Increased by 18.46%
EPS This Year
0.42
from 0.15
Increased by 168.15%
EPS Next Year
0.53
from 0.42
Increased by 27.94%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
89.19M122.78M169.80M260.21M338.96M
Revenue Growth
-37.67%38.29%53.25%30.26%
Gross Profit
42.79M69.97M102.88M170.94M241.47M
Gross Margin
47.98%56.99%60.59%65.69%71.24%
Operating Income
-72.35M-66.00M-43.65M-11.97M-2.44M
Net Income
-72.52M-67.51M-47.14M-12.78M2.96M
EPS
---0.150.42
EPS Growth
----168.15%
Forward PE
----60.17
Free Cash Flow
--29.39M-14.46M15.34M25.40M
No. Analysts
----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High344.4M
Avg339.0M
Low337.0M

Revenue Growth

Revenue Growth202620272028
High
32.4%
Avg
30.3%
Low
29.5%

EPS Forecast

EPS202620272028
High0.48
Avg0.42
Low0.31

EPS Growth

EPS Growth202620272028
High
210.5%
Avg
168.1%
Low
97.3%